Universal and specific quantitative detection of botulinum neurotoxin genes

BMC Microbiology

Volumn 10, Issue , 2010, Pages

  Hill, Brenna J ^a   Skerry, Janet C ^b   Smith, Theresa J ^b   Arnon, Stephen S ^c   Douek, Daniel C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c Infant Botulism Treatment and Prevention Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BOTULINUM TOXIN; NEUROTOXIN; PLASMID DNA;

ARTICLE; BIOASSAY; BOTULISM; CLINICAL ARTICLE; CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM; CONTROLLED STUDY; FECES ANALYSIS; FOOD ANALYSIS; GENE EXPRESSION; HUMAN; INFANT; LD 50; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEROTYPE; TOXIN ANALYSIS; BACTERIAL GENE; FOOD CONTROL; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; SENSITIVITY AND SPECIFICITY;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIUM BOTULINUM;

BIOLOGICAL ASSAY; BOTULINUM TOXINS; CLOSTRIDIUM BOTULINUM; DNA, BACTERIAL; FOOD MICROBIOLOGY; GENES, BACTERIAL; HUMANS; INFANT; NEUROTOXINS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 77958009986     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-10-267     Document Type: Article

References (57)

1. Clostridial neurotoxins: the molecular pathogenesis of tetanus and botulism. C Montecucco, Current Topics of Microbial immunology 1995 195 1 278
2. Bacterial toxins: a table of lethal amounts. DM Gill, Microbiol Rev 1982 46 1 86 94 6806598
3. Botulinal neurotoxins: revival of an old killer. C Montecucco J Molgo, Curr Opin Pharmacol 2005 5 3 274 279 10.1016/j.coph.2004.12.006 15907915
4. Botulinum toxin as a biological weapon: medical and public health management. SS Arnon R Schechter TV Inglesby DA Henderson JG Bartlett MS Ascher E Eitzen AD Fine J Hauer M Layton,, et al. Jama 2001 285 8 1059 1070 10.1001/jama.285.8.1059 11209178 (Pubitemid 32176420)
5. Centers for Disease Control and Prevention: Botulism in the United States, 1899-1996. Handbook for Epidemiologists, Clinicians, and Laboratory Workers, Atlanta, GA. Centers for Disease Control C, Centers for Disease Control and Prevention 1998
6. Global Occurrence of Infant Botulism, 1976-2006. RJS Koepke SS Arnon, Pediatrics 2008
7. Wound botulism in injectors of drugs: upsurge in cases in England during 2004. D Akbulut J Dennis M Gent KA Grant V Hope C Ohai J McLauchlin V Mithani O Mpamugo F Ncube,, et al. Euro Surveill 2005 10 9 172 174 16280612
8. First case of type E wound botulism diagnosed using real-time PCR. I Artin P Bjorkman J Cronqvist P Radstrom E Holst, J Clin Microbiol 2007 45 11 3589 3594 10.1128/JCM.01192-07 17881556
9. Botulism. J Sobel, Clin Infect Dis 2005 41 8 1167 1173 10.1086/444507 16163636
10. Isolation of an organism resembling Clostridium barati which produces type F botulinal toxin from an infant with botulism. JD Hall LM McCroskey BJ Pincomb CL Hatheway, J Clin Microbiol 1985 21 4 654 655 3988908
11. Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. LM McCroskey CL Hatheway L Fenicia B Pasolini P Aureli, J Clin Microbiol 1986 23 1 201 202 3517043
12. Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins. O Dolly, Headache 2003 43 Suppl 1 16 24 10.1046/j.1526-4610. 43.7s.4.x 12887390
13. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. G Schiavo F Benfenati B Poulain O Rossetto P Polverino de Laureto BR DasGupta C Montecucco, Nature 1992 359 6398 832 835 10.1038/359832a0 1331807
14. Botulinum neurotoxins are zinc proteins. G Schiavo O Rossetto A Santucci BR DasGupta C Montecucco, J Biol Chem 1992 267 33 23479 23483 1429690
15. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. P Foran GW Lawrence CC Shone KA Foster JO Dolly, Biochemistry 1996 35 8 2630 2636 10.1021/bi9519009 8611567
16. Creation and development of the public service orphan drug Human Botulism Immune Globulin. SS Arnon, Pediatrics 2007 119 4 785 789 10.1542/peds.2006-0646 17403850
17. Human botulism immune globulin for the treatment of infant botulism. SS Arnon R Schechter SE Maslanka NP Jewell CL Hatheway, N Engl J Med 2006 354 5 462 471 10.1056/NEJMoa051926 16452558
18. Laboratory diagnostics of botulism. M Lindstrom H Korkeala, Clin Microbiol Rev 2006 19 2 298 314 10.1128/CMR.19.2.298-314.2006 16614251
19. Bacteriological Analytical Manual online - Clostridium botulinum. HM Solomon T Lilly Jr, Chapter 17 - Clostridium botulinum Center for Food Safety and Applied Nutrition, Food and Drug Administration, RI M, 2001
20. Gene probes for identification of the botulinal neurotoxin gene and specific identification of neurotoxin types B, E, and F. KD Campbell MD Collins AK East, J Clin Microbiol 1993 31 9 2255 2262 8408542
21. Development of a combined selection and enrichment PCR procedure for Clostridium botulinum Types B, E, and F and its use to determine prevalence in fecal samples from slaughtered pigs. M Dahlenborg E Borch P Radstrom, Appl Environ Microbiol 2001 67 10 4781 4788 10.1128/AEM.67.10.4781-4788.2001 11571185
22. PCR and gene probe identification of botulinum neurotoxin A-, B-, E-, F-, and G-producing Clostridium spp. and evaluation in food samples. P Fach M Gibert R Griffais JP Guillou MR Popoff, Appl Environ Microbiol 1995 61 1 389 392 7887623
23. Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material. M Lindstrom R Keto A Markkula M Nevas S Hielm H Korkeala, Appl Environ Microbiol 2001 67 12 5694 5699 10.1128/AEM.67.12.5694-5699.2001 11722924
24. Quantification of Clostridium botulinum toxin gene expression by competitive reverse transcription-PCR. S McGrath JS Dooley RW Haylock, Appl Environ Microbiol 2000 66 4 1423 1428 10.1128/AEM.66.4.1423-1428.2000 10742222
25. Detection of the genes encoding botulinum neurotoxin types A to E by the polymerase chain reaction. EA Szabo JM Pemberton PM Desmarchelier, Appl Environ Microbiol 1993 59 9 3011 3020 8215372
26. The detection of a deletion in the type B neurotoxin gene of Clostridium botulinum A(B) strains by a two-step PCR. G Franciosa CL Hatheway P Aureli, Lett Appl Microbiol 1998 26 6 442 446 10.1046/j.1472-765X.1998.00367.x 9717316
27. Development and application of Real-Time PCR assays to detect fragments of the Clostridium botulinum types A, B, and E neurotoxin genes for investigation of human foodborne and infant botulism. D Akbulut KA Grant J McLauchlin, Foodborne Pathog Dis 2004 1 4 247 257 10.1089/fpd.2004.1.247 15992287
28. Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments. D Akbulut KA Grant J McLauchlin, J Clin Microbiol 2005 43 9 4342 4348 10.1128/JCM.43.9.4342-4348.2005 16145075
29. Rapid, quantitative PCR monitoring of growth of Clostridium botulinum type E in modified-atmosphere-packaged fish. B Kimura S Kawasaki H Nakano T Fujii, Appl Environ Microbiol 2001 67 1 206 216 10.1128/AEM.67.1.206-216.2001 11133447
30. Real-time PCR quantitation of clostridia in feces of autistic children. Y Song C Liu SM Finegold, Appl Environ Microbiol 2004 70 11 6459 6465 10.1128/AEM.70.11.6459-6465.2004 15528506
31. Application of real-time PCR for quantitative detection of Clostridium botulinum type A toxin gene in food. SY Yoon GT Chung DH Kang C Ryu CK Yoo WK Seong, Microbiol Immunol 2005 49 6 505 511 15965297
32. Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. KK Hill TJ Smith CH Helma LO Ticknor BT Foley RT Svensson JL Brown EA Johnson LA Smith RT Okinaka,, et al. J Bacteriol 2007 189 3 818 832 10.1128/JB.01180-06 17114256
33. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. TJ Smith J Lou IN Geren CM Forsyth R Tsai SL Laporte WH Tepp M Bradshaw EA Johnson LA Smith,, et al. Infect Immun 2005 73 9 5450 5457 10.1128/IAI.73.9.5450-5457.2005 16113261
34. Purification and some properties of Clostridium botulinum type-E toxin. M Kitamura S Sakaguchi G Sakaguchi, Biochim Biophys Acta 1968 168 2 207 217 4972262
35. Purification and some properties of progenitor toxins of Clostridium botulinum type B. S Kozaki S Sakaguchi G Sakaguchi, Infect Immun 1974 10 4 750 756 4214781
36. Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties. S Miyazaki M Iwasaki G Sakaguchi, Infect Immun 1977 17 2 395 401 892912
37. Purification of Clostridium botuliunum type F progenitor toxin. I Oishi G Sakaguchi, Appl Microbiol 1974 28 6 923 928 4615636
38. Real-time PCR detection of the nontoxic nonhemagglutinin gene as a rapid screening method for bacterial isolates harboring the botulinum neurotoxin (A-G) gene complex. BH Raphael JD Andreadis, J Microbiol Methods 2007 71 3 343 346 10.1016/j.mimet.2007.09.016 17961766
39. Sequencing the botulinum neurotoxin gene and related genes in Clostridium botulinum type E strains reveals orfx3 and a novel type E neurotoxin subtype. Y Chen H Korkeala J Aarnikunnas M Lindstrom, J Bacteriol 2007 189 23 8643 8650 10.1128/JB.00784-07 17905976
40. Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective. EA Johnson M Bradshaw, Toxicon 2001 39 11 1703 1722 10.1016/S0041-0101(01)00157-X 11595633
41. Clostridium botulinum: a bug with beauty and weapon. HD Shukla SK Sharma, Crit Rev Microbiol 2005 31 1 11 18 10.1080/10408410590912952 15839401
42. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals. M Dezfulian JG Bartlett, J Clin Microbiol 1984 19 5 645 648 6376538 (Pubitemid 14142653)
43. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type A and type B toxins in stool samples of infants with botulism. M Dezfulian CL Hatheway RH Yolken JG Bartlett, J Clin Microbiol 1984 20 3 379 383 6490825 (Pubitemid 14073391)
44. Immunological detection of Clostridium botulinum toxin type A in therapeutic preparations. TA Ekong K McLellan D Sesardic, J Immunol Methods 1995 180 2 181 191 10.1016/0022-1759(94)00313-L 7714333
45. Development of sensitive colorimetric capture ELISAs for Clostridium botulinum neurotoxin serotypes E and F. MA Poli VR Rivera D Neal, Toxicon 2002 40 6 797 802 10.1016/S0041-0101(01)00288-4 12175617
46. Rapid identification of Clostridium botulinum and botulinal toxin in food. A Rodriguez M Dezfulian, Folia Microbiol (Praha) 1997 42 2 149 151 10.1007/BF02898726 9306659
47. Detection of Clostridium botulinum neurotoxin type A using immuno-PCR. HC Wu YL Huang SC Lai YY Huang MF Shaio, Lett Appl Microbiol 2001 32 5 321 325 10.1046/j.1472-765X.2001.00909.x 11328498
48. Polymerase chain reaction for detection of Clostridium botulinum types A, B and E in food, soil and infant faeces. EA Szabo JM Pemberton AM Gibson MJ Eyles PM Desmarchelier, J Appl Bacteriol 1994 76 6 539 545 8027003
49. Bacteriophage and the toxigenicity of Clostridium botulinum type C. MW Eklund FT Poysky SM Reed CA Smith, Science 1971 172 982 480 482 10.1126/science.172.3982.480 4927679
50. Bacteriophage and the toxigenicity of Clostridium botulinum type D. MW Eklund FT Poysky SM Reed, Nat New Biol 1972 235 53 16 17 4553461
51. Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G. MW Eklund FT Poysky LM Mseitif MS Strom, Appl Environ Microbiol 1988 54 6 1405 1408 2843093
52. Detection of Clostridium botulinum types A, B, E and F in foods by PCR and DNA probe. E Aranda MM Rodriguez MA Asensio JJ Cordoba, Lett Appl Microbiol 1997 25 3 186 190 10.1046/j.1472-765X.1997.00204.x 9351261
53. Cloth-based hybridization array system for the detection of Clostridium botulinum type A, B, E, and F neurotoxin genes. M Gauthier B Cadieux JW Austin BW Blais, J Food Prot 2005 68 7 1477 1483 16013391 (Pubitemid 40950604)
54. [Existence of type D botulism in man.]. J Demarchi C Mourgues J Orio AR Prevot, Bull Acad Natl Med 1958 142 21-22 580 582 13560962
55. Infant botulism due to Clostridium botulinum type C toxin. K Oguma K Yokota S Hayashi K Takeshi M Kumagai N Itoh N Tachi S Chiba, Lancet 1990 336 8728 1449 1450 10.1016/0140-6736(90)93157-K 1978909
56. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. W Jiang MM Lederman P Hunt SF Sieg K Haley B Rodriguez A Landay J Martin E Sinclair AI Asher,, et al. J Infect Dis 2009 199 8 1177 1185 10.1086/597476 19265479
57. NIAID Expert Panel on Botulism Diagnostics. NIAID, NIAD Expert Panel on Botulism Diagnostics: May 23, 2003 2003; Bethesda, Maryland NIAID 2003 1 14